跳至主要内容
临床试验/NCT00538512
NCT00538512已完成4 期

Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4

University of Michigan8 个研究点 分布在 1 个国家目标入组 1,952 人开始时间: 2007年9月最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
1,952
试验地点
8
主要终点
Laboratory-confirmed (Culture and/or PCR) Symptomatic Influenza

研究概览

简要总结

The purpose of this study is to evaluate the absolute (versus placebo) and relative (one vaccine compared to the other) efficacies of the live attenuated and inactivated influenza vaccines in preventing laboratory confirmed symptomatic influenza caused by circulating strains whether similar or dissimilar to strains included in the vaccines.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 49 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy adult men and women
  • Age 18-49 years
  • Who reside geographically close to one of the four study sites in Michigan

排除标准

  • Persons with any of the health conditions for which the inactivated vaccine is recommended
  • Persons for whom either vaccine is contraindicated

研究组 & 干预措施

TIV

Active Comparator

the trivalent inactivated influenza vaccine - Fluzone, manufactured by Sanofi-Pasteur

干预措施: Fluzone (Biological)

LAIV

Active Comparator

live-attenuated influenza vaccine Flumist, manufactured by MedImmune

干预措施: Flumist (Biological)

Placebo

Placebo Comparator

Physiologic saline administered as a nasal spray or intramuscular injection

干预措施: Physiologic saline (Other)

结局指标

主要结局

Laboratory-confirmed (Culture and/or PCR) Symptomatic Influenza

时间窗: one influenza season - 2007-2008

次要结局

  • Measure Immune Response Induced by the Vaccines and Identify Serologic Correlates of Immune Protection(Time between prevaccination visit and postvaccination visit; typically about 30 days.)
  • Immune Response to Vaccination and Infection(Postvaccination to postseason visit; typically about 3 months.)
  • Identify Serologic Correlates of Immune Protection. Suggest Changing to: Number of Participants Demonstrating Postvaccination Seroconversion.(Time between prevaccination and postvaccination, typically about 30 days.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Arnold S. Monto

Principal Investigator

University of Michigan

研究点 (8)

Loading locations...

相似试验